Patents by Inventor Rebecca Anthouard MCDONALD

Rebecca Anthouard MCDONALD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11813270
    Abstract: Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: November 14, 2023
    Assignee: KNOW BIO, LLC
    Inventors: Drew Folk, Ryan Gerald Anderson, John Kelly Simons, Mona Jasmine Rosales Ahonen, Rebecca Anthouard McDonald
  • Publication number: 20230337678
    Abstract: Methods of sanitizing, disinfecting, decontaminating, and/or sterilizing surfaces with small molecule NO releasing compounds are disclosed. In some embodiments, the compounds are covalently modified to store and release nitric oxide. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for preventing the spread of microbial infections, such as nocosomial infections.
    Type: Application
    Filed: February 5, 2021
    Publication date: October 26, 2023
    Inventors: Drew Folk, Ryan Gerald Anderson, John Kelly Simons, Mona Jasmine Rosales Ahonen, Rebecca Anthouard McDonald
  • Publication number: 20230108186
    Abstract: Methods of treating baldness, fibrotic disease, cancer and other pathological conditions resulting from abnormal cell proliferation, cardiovascular disease, metabolic syndrome, central nervous system disorders, platelet aggregation, platelet adhesion, disease caused by or characterized by low nitric oxide levels, transplantation rejections, autoimmune diseases, inflammation, vascular diseases, restenosis, pain, fever, gastrointestinal disorders, respiratory disorders, and sexual dysfunctions are disclosed. The methods involve administering specific nitric oxide-releasing compounds.
    Type: Application
    Filed: February 5, 2021
    Publication date: April 6, 2023
    Inventors: Drew Folk, Ryan Gerald Anderson, John Kelly Simons, Mona Jasmine Rosales Ahonen, Rebecca Anthouard McDonald
  • Publication number: 20220160736
    Abstract: Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.
    Type: Application
    Filed: February 5, 2021
    Publication date: May 26, 2022
    Inventors: Drew FOLK, Ryan Gerald ANDERSON, John Kelly SIMONS, Mona Jasmine Rosales AHONEN, Rebecca Anthouard MCDONALD
  • Publication number: 20220152063
    Abstract: Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.
    Type: Application
    Filed: December 3, 2021
    Publication date: May 19, 2022
    Inventors: Drew FOLK, Ryan Gerald ANDERSON, John Kelly SIMONS, Mona Jasmine Rosales AHONEN, Rebecca Anthouard MCDONALD